Skip to main content
AbbVie Inc.
Healthcare · Drug Manufacturers - General
Made on Jun 24, 2026
Price at call $234.76
6-month call Neutral -2.1%
Target by Dec 2026 $229.92
Great value below $195.00
Model v0.3.0

Projection vs Actual (6M history + forecast)

Our straight 6-month prediction (bold) with a textured realism line, and the actual price overlaid from the prediction date forward.

Forecast

One directional 6-month call and the six monthly points we'll be scored against. Predicted Jun 24, 2026 3:09 am
Neutral ABBV trends range-bound to $229.92 (-2.1% from $234.76) by Dec 2026.
Monthmonths after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $234.76 at call
Prediction made Jun 24, 2026 $234.76 at call
M1 Jul 24, 2026 $233.95 -0.3%
What actually happened: closed $256.92 on Jul 23, 2026 = +9.4% vs the call (predicted -0.4%)  ·  direction MISS (called flat, was up)  ·  off by 9.8 pp  ·  accuracy 4/10  ·  S&P +0.7% over the same window — lagged it
M2 Aug 24, 2026 $233.15 -0.7%
M3 Sep 24, 2026 $232.34 -1.0%
M4 Oct 24, 2026 $231.54 -1.4%
M5 Nov 24, 2026 $230.73 -1.7%
M6 Dec 24, 2026 $229.92 -2.1%

Deserved value (DCF/composite) is $208.54; over 6 months we project closing only part-way to it (reach 18.5%). Value-only — see Not Yet Modeled below.

Weaknesses

0 blocking · 0 degraded · 3 notes — follow the chain top-down (cause → effect).
  • Note
    EPV de-weighted — growth IS the value proposition for this type of company
    upstream:classification
  • Note
    Valuation anchor absent: dcf.
    anchor:dcf
  • Note
    Valuation anchor absent: anchored_pe.
    anchor:anchored_pe

Equation Inputs

Everything feeding the v0.3.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$234.76
Composite fair value$189.93
Signal-adjusted fair value$189.93
DCF fair value
Anchored-PE fair value
Buy-below (value lens)$195.00
Value net score-77
Value confidence7 / 10
Quality net score+49
Memo confidence7 / 10
Deserved value (base)$189.93
Quality tilt+9.8%
Deserved value (used)$208.54
Coherence (value × quality)0.50

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 31.3%  3m 26.7%  6m 27.0%  
Daily σ (realism noise)1.7%
Beta vs S&P 500 1m -0.58  3m -0.17  5m 0.04  
Trailing 6-month return5.4%

Knobs (equation params)

Deserved wt · DCF0.5
Quality tilt cap (±)0.2
Horizon reach (6mo)0.45
Coherence floor (conflict)0.5
Conviction gain / pt0.06
Realism mean-reversion φ0.85
Conviction floor0.4
Deserved wt · composite0.5
Realism vol window3m
Neutral band (%)5
Horizon (months)6
Realism σ fallback0.015

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.3.0 #6bd904191719

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Jun 24, 2026 freshest ABBV-20260624-030001-06d4
ext-forensic-memo Jun 24, 2026 freshest ext-ABBV-20260624-030752-a2c5
ext-lens-quality Jun 24, 2026 freshest ext-ABBV-20260624-030752-a2c5
ext-lens-value Jun 24, 2026 freshest ext-ABBV-20260624-030752-a2c5
scenario-valuation Jun 24, 2026 freshest ABBV-20260624-030001-06d4
valuation-synthesis Jun 24, 2026 freshest ABBV-20260624-030001-06d4

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Jul 31, 2026 v0.6.0 Bear $257.41 $244.00 -5.2% Jan 2027 view
Jun 24, 2026 v0.3.0 Neutral $234.76 $229.92 -2.1% Dec 2026 viewing

Not Yet Modeled

What this v0.3.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Signal-adjusted fair value ($189.93) — the red-flag-adjusted anchor isn't the primary input yet (we use the raw DCF/composite blend, which double-counts DCF).
  • Recent momentum / drift — the line takes off straight; the trailing 6-month move (5.4%) doesn't bend the slope.
  • Market beta — computed (1–5mo) for context but does not condition the path.
  • Earnings dates, catalysts, and known events — not modeled.
  • Macro regime & sector rotation — not modeled.
  • Horizon is a fixed 6-month assumption, not a modeled time-to-target.
  • Outcome scoring — predictions aren't yet graded against realized price once the evaluation date passes.